What is the recommended daily dose of Victoza (liraglutide) for diabetes management?

Victoza Daily Dosing

Start Victoza at 0.6 mg subcutaneously once daily for one week, then increase to 1.2 mg daily, with a maximum dose of 1.8 mg daily if additional glycemic control is needed. 1

Dosing Algorithm

Adult Patients

Initial Titration:

• Week 1: 0.6 mg subcutaneously once daily
  • This starting dose reduces gastrointestinal symptoms but is NOT effective for glycemic control 1
• Week 2 onward: Increase to 1.2 mg once daily
• If needed: After at least one additional week at 1.2 mg, increase to maximum dose of 1.8 mg once daily 1

Pediatric Patients (≥10 years)

• Start: 0.6 mg subcutaneously once daily
• Titration: Increase in 0.6 mg increments after at least one week on current dose
• Maximum: 1.8 mg once daily 1

Administration Details

Timing and Technique:

• Inject once daily at any time of day, independent of meals 1
• Administer subcutaneously in abdomen, thigh, or upper arm
• Rotate injection sites within the same region to reduce cutaneous amyloidosis risk 1
• When using with insulin, give as separate injections—never mix 1

Missed Dose Management

Critical Pitfall: If more than 3 days have elapsed since the last dose, restart at 0.6 mg daily to mitigate gastrointestinal symptoms, then retitrate 1

For missed doses within 3 days: Simply resume the regular schedule with the next dose—do not double up 1

Renal Considerations

Important: Liraglutide requires no dosage adjustments for renal impairment 2. This distinguishes it from other GLP-1 receptor agonists like exenatide (not recommended with CrCl <30) or lixisenatide (not recommended with CrCl <15) 2.

Context-Specific Dosing

For Diabetes (Victoza): Maximum 1.8 mg daily 2, 3

For Obesity (Saxenda—different formulation): Maximum 3.0 mg daily, titrated weekly by 0.6 mg increments starting from 0.6 mg 4, 3

The evidence consistently shows liraglutide's half-life of 13 hours supports once-daily dosing 3. The weekly titration schedule balances efficacy with tolerability, as gastrointestinal side effects (nausea, vomiting) are dose-dependent and diminish over time 5, 6, 7.